Table 2. Infarct size and echocardiogram.
| Vectors (n) | Infarct size, % | LVDd, mm | LVDs, mm | FS(%) |
|---|---|---|---|---|
| CMVVEGF (5) | 37 ± 11 | 4.45 ± 0.19 | 3.06 ± 0.41 | 31.4 ± 6.4 |
| MLCVEGF (8) | 38 ± 7 | 4.42 ± 0.60 | 3.09 ± 0.87 | 31.2 ± 9.9 |
| CMVLacZ (6) | 46 ± 6 | 4.54 ± 0.20 | 3.34 ± 0.51 | 26.6 ± 8.9 |
| Hepes (5) | 46 ± 5 | 4.72 ± 0.17 | 3.69 ± 0.25 | 21.8 ± 4.6 |
| Uninjected (7) | 49 ± 8 | 4.57 ± 0.18 | 3.43 ± 0.28 | 24.8 ± 5.6 |
| Normal (4) | 0 | 3.60 ± 0.18 | 1.67 ± 0.29 | 53.8 ± 6.2 |
LVDd, left ventricular end diastolic dimension; LVDs, left ventricular end systolic dimension; FS(%), percentage of fractional shortening, calculated as (LVDd-LVDs)/LVDd × 100; n, number of animals used in each group. Infarct size was measured as a percentage of the left ventricular wall.